RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection
Clinical trial NCT06149494 · COMPLETED
Trial details
- NCT number
- NCT06149494
- Sponsor
- Altesa Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-20
- Primary completion
- 2025-03-30
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.